Sökning: "IFNg"
Visar resultat 1 - 5 av 13 avhandlingar innehållade ordet IFNg.
1. Immunohistochemical study of rats receiving peripheral immunization with IFNg transfected glioma cells
Sammanfattning : Malignant glioma is, with rare exceptions in younger adults, an uncurable brain tumor, as very few survive more than 1-2 years after diagnosis. Despite advances in recent years, current treatments such as surgery, radiotherapy and chemotherapy only prolongs the life of the patients. LÄS MER
2. Mechanisms involved in the regulation of secretory phospholipase A2 Type IIA expression in human arterial smooth muscle cells. Potential role in atherogenesis
Sammanfattning : Experimental and clinical evidence indicates that secretory phospholipase A2 group IIA (sPLA2-IIA) contributes to atherogenesis. Activity of sPLA2-IIA may be pro-atherogenic both in the circulation leading to altered lipoprotein profile and/or locally in the artery wall where it contributes to lipid accumulation both intra and extra cellularly. LÄS MER
3. Transcriptional control of CD4+ T lymphocytes
Sammanfattning : The immune system can respond to various types of pathogens such as bacteria, viruses, tumors and parasites. The ability to provide protection against different types of pathogens partly relies on development of alternative T effector cells with separate effector functions. LÄS MER
4. Autocrine growth stimulation in human bladder cancer
Sammanfattning : Bladder cancer is one of the most common human cancers which, on a worldwide basis, represents 3-4 % of all malignancies. It is primarily occuring in people over 60 and males are about 2-3 times more likely to develop bladder cancer than are women. LÄS MER
5. Langerhans cells in oral mucosa and skin. A functional and morphological study
Sammanfattning : Langerhans cells (LC) are a subpopulation of dendritic cells residing in skin and mucosal epi-thelium. LC capture antigens in the periphery and following migration to regional lymph nodes present peptides to T cells. LCs have a central role in initiating a T cell mediated immune re-sponse, both in health and disease. LÄS MER